Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release
Hana Starobova(The University of Queensland), Irina Vetter(Centre National de la Recherche Scientifique), Lena Batoon(Mayo Clinic in Arizona), Kate Schroder(The University of Queensland), Mercedes Monteleone(The University of Queensland), Allison R. Pettit(Translational Research Institute), Elissa Tolson(The University of Queensland), Grace Lawrence(The University of Queensland), Jean-Pierre Lévesque(The University of Queensland), Alexander Mueller(Princeton University), Cheyenne J. Sandrock(Translational Research Institute), Jennifer R. Deuis(The University of Queensland), Evelyn Israel Nadar(The University of Queensland), Christelle Adolphe(The University of Queensland), Alexandra V. Smith(The University of Queensland), Bryan Tay(The University of Queensland), Amanda Mayor(The University of Queensland), Brandon J. Wainwright(The University of Queensland)
Cited by 64
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
|Nature Chemical Biology|2019|975
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Noncanonical inflammasome signaling elicits gasdermin D–dependent neutrophil extracellular traps
|Science Immunology|2018|608